Cargando…

Health Canada: AKI or ARF with remdesivir for COVID-19?

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062813/
http://dx.doi.org/10.1007/s40278-021-94457-0
_version_ 1783681840525082624
collection PubMed
description
format Online
Article
Text
id pubmed-8062813
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80628132021-04-23 Health Canada: AKI or ARF with remdesivir for COVID-19? Reactions Weekly News Item Springer International Publishing 2021-04-24 2021 /pmc/articles/PMC8062813/ http://dx.doi.org/10.1007/s40278-021-94457-0 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Health Canada: AKI or ARF with remdesivir for COVID-19?
title Health Canada: AKI or ARF with remdesivir for COVID-19?
title_full Health Canada: AKI or ARF with remdesivir for COVID-19?
title_fullStr Health Canada: AKI or ARF with remdesivir for COVID-19?
title_full_unstemmed Health Canada: AKI or ARF with remdesivir for COVID-19?
title_short Health Canada: AKI or ARF with remdesivir for COVID-19?
title_sort health canada: aki or arf with remdesivir for covid-19?
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062813/
http://dx.doi.org/10.1007/s40278-021-94457-0